Avanos Medical Inc
(AVNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 205,300 | 384,500 | 219,700 | 113,700 | 129,500 |
| Receivables | 163,800 | 150,500 | 203,000 | 188,500 | 224,700 |
| Inventories | 145,900 | 121,400 | 91,100 | 80,700 | 303,200 |
| Other current assets | 0 | 0 | 632,500 | 194,000 | 0 |
| TOTAL | $538,500 | $713,600 | $1,160,700 | $593,500 | $676,000 |
| Non-Current Assets | |||||
| PPE Net | 184,500 | 154,100 | 109,900 | 109,300 | 279,500 |
| Intangibles | 985,200 | 951,800 | 913,600 | 930,500 | 1,027,800 |
| Other Non-Current Assets | 91,400 | 13,900 | 11,700 | 438,500 | 16,900 |
| TOTAL | $1,261,100 | $1,119,800 | $1,035,200 | $1,478,300 | $1,324,200 |
| Total Assets | $1,799,600 | $1,833,400 | $2,195,900 | $2,071,800 | $2,000,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 39,800 | N/A | N/A |
| Accounts payable and accrued liabilities | 83,000 | 169,900 | 171,200 | 160,600 | 163,200 |
| Accrued Expenses | 114,800 | 94,400 | 144,900 | 138,400 | 152,000 |
| Other current liabilities | N/A | N/A | 33,900 | 25,400 | N/A |
| TOTAL | $212,500 | $264,300 | $389,800 | $324,400 | $315,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 248,100 | 247,700 | 541,100 | 579,000 | 578,100 |
| Other Non-Current Liabilities | 73,800 | 19,800 | 31,800 | 30,500 | 27,800 |
| TOTAL | $321,900 | $271,900 | $590,700 | $644,900 | $629,700 |
| Total Liabilities | $534,400 | $536,200 | $980,500 | $969,300 | $944,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,755 | 47,453 | 46,920 | 46,682 | 46,615 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | -288,300 | -242,400 | -299,900 | -379,200 | -419,000 |
| Other shareholders' equity | -31,900 | -34,000 | -31,700 | -50,000 | -43,200 |
| TOTAL | $1,265,200 | $1,297,200 | $1,215,400 | $1,102,500 | $1,055,300 |
| Total Liabilities And Equity | $1,799,600 | $1,833,400 | $2,195,900 | $2,071,800 | $2,000,200 |